Year of investment:
2021
Turnover:
SEK 300m
Fund:
Priveq Investment VI
Ownership:
Minority
CEO:
Martin Sjögren
Phone:
+46 13 37 40 30
Swemac strives continuously to provide the market with innovative and practical solutions for fracture treatment and joint replacement to benefit patients and health care professionals. Swemac has evolved over the years within a highly innovative environment where quality has always been critical to development and production. This strong tradition of innovation and high quality remains a core characteristic and guiding compass for Swemac today. The products are currently sold via Swemac’s own sales organization in the Nordics and through distributors on international markets. Also 3rd party brands within trauma treatment and medical imaging are distributed by Swemac in the Nordics.
The company is headquartered in Linköping and has around 80 employees.
Members of the Board
Ulf Mattsson (Chairman of the Board), Karl Hagström, Henrik Hansson, Mattias Hansson, Anders Nilsson, Senai Ayob
Priveq team
Senai Ayob, Magnus Hardmeier, Daniel Nylund
For further information, please contact
Senai Ayob
Partner & Investment Manager
Telefon: +46 8 459 67 69
Mobil: +46 70 459 23 61
E-post: senai.ayob@priveq.se